1-3 of 3
Teresa J. Melink
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Clinical Trial of Carbetimer

Axel-R. Hanauske, Teresa J. Melink, Glenn S. Harman, Gary M. Clark, John B. Craig, Jim M. Koeller, David H. Boldt, Beverly Kantor, Daniel L. Kisner, Gayle Orczyk, David W. Anderson, Edward Paget, Gisele A. Sarosy, Daniel D. Von Hoff
Journal: Cancer Research
Cancer Res (1988) 48 (18): 5353–5357.
Published: 01 September 1988
View articletitled, Phase I Clinical Trial of Carbetimer
Open the PDF for Phase I Clinical Trial of Carbetimer in another window
Journal Articles

Phase I Evaluation and Pharmacokinetics of Tiazofurin (2-β-d-Ribofuranosylthiazole-4-carboxamide, NSC 286193)1

Teresa J. Melink, Daniel D. Von Hoff, John G. Kuhn, Marla R. Hersh, Lawrence A. Sternson, Thomas F. Patton, Robert Siegler, David H. Boldt, Gary M. Clark
Journal: Cancer Research
Cancer Res (1985) 45 (6): 2859–2865.
Published: 01 June 1985
View articletitled, Phase I Evaluation and Pharmacokinetics of Tiazofurin (2-β-d-Ribofuranosylthiazole-4-carboxamide, NSC 286193)1
Open the PDF for Phase I Evaluation and Pharmacokinetics of Tiazofurin (2-β-d-Ribofuranosylthiazole-4-carboxamide, NSC 286193)1 in another window
Journal Articles

Interferon-α Therapy of Renal Cancer

James A. Neidhart, Mary M. Gagen, Donn Young, Richard Tuttle, Teresa J. Melink, Andrea Ziccarrelli, Daniel Kisner
Journal: Cancer Research
Cancer Res (1984) 44 (9): 4140–4143.
Published: 01 September 1984
View articletitled, Interferon-α Therapy of Renal Cancer
Open the PDF for Interferon-α Therapy of Renal Cancer in another window